SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY

Clinical trials for SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug trial targets root cause of inherited heart failure

Disease control Recruiting now

This study is testing an investigational drug called danicamtiv for people with a genetic form of dilated cardiomyopathy, a condition where the heart muscle is weak and enlarged. About 332 participants will take either danicamtiv or a placebo pill daily for six months to see if t…

Matched conditions: SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY

Phase: PHASE2, PHASE3 • Sponsor: Kardigan, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY

Get alerted when new SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY trials appear

New drug trial targets root cause of inherited heart failure